SEK 274
Key Takeaways
Risk factor
Limited default risk
Profitability factor
Strong growth
About
RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy,...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, overvalu
Target Price
The average target price of RAY-B.ST is 366 and suggests 33% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc